92 related articles for article (PubMed ID: 6182997)
1. [The incidence of hyperamylasemia in tumor diseases of the prostate].
Skrha J; Stĕpán J; Vachalovský V; Hradec E; Marek J
Cas Lek Cesk; 1982 Sep; 121(38-39):1195-8. PubMed ID: 6182997
[No Abstract] [Full Text] [Related]
2. Nonassociation of hyperamylasemia and prostatic disease.
Lehner LM; Melman A
Urology; 1978 Oct; 12(4):461-2. PubMed ID: 82285
[TBL] [Abstract][Full Text] [Related]
3. [Expression of COX-2 in prostatic cancer and benign prostatic hyperplasia].
Zang T; Sun F; Li Y
Zhonghua Wai Ke Za Zhi; 2001 Sep; 39(9):702-3. PubMed ID: 11769607
[TBL] [Abstract][Full Text] [Related]
4. Preliminary report on the effect of medroxyprogesterone acetate on human prostate LDH-isoenzymes.
Rutten J; van Sande M; Van Camp K
Acta Urol Belg; 1977 Jan; 45(1):28-30. PubMed ID: 67788
[No Abstract] [Full Text] [Related]
5. Lactate dehydrogenase isoenzymes in benign and malignant prostatic tissues.
Mazzuca A; Lalanne GM
Boll Soc Ital Biol Sper; 1980 Apr; 56(7):690-2. PubMed ID: 6160867
[TBL] [Abstract][Full Text] [Related]
6. Expression of cyclooxygenase-2 in prostate adenocarcinoma and benign prostatic hyperplasia.
Lee LM; Pan CC; Cheng CJ; Chi CW; Liu TY
Anticancer Res; 2001; 21(2B):1291-4. PubMed ID: 11396201
[TBL] [Abstract][Full Text] [Related]
7. [Molecular forms of prostate-specific antigen and their clinical significance].
Hilz H
Urologe A; 1995 Jul; 34(4):275-82. PubMed ID: 7545841
[TBL] [Abstract][Full Text] [Related]
8. Expression of human prostatic acid phosphatase and prostate specific antigen genes in neoplastic and benign tissues.
Sharief FS; Mohler JL; Sharief Y; Li SS
Biochem Mol Biol Int; 1994 Jun; 33(3):567-74. PubMed ID: 7524903
[TBL] [Abstract][Full Text] [Related]
9. Preliminary report on the effect of gestonorone capronate on human prostate LDH-isoenzymes.
Govaerts J; van Sande M; Van Camp K
Acta Urol Belg; 1978; 46(4):389-92. PubMed ID: 83788
[No Abstract] [Full Text] [Related]
10. Expression of protein kinase C isoenzymes in benign hyperplasia and carcinoma of prostate.
Koren R; Ben Meir D; Langzam L; Dekel Y; Konichezky M; Baniel J; Livne PM; Gal R; Sampson SR
Oncol Rep; 2004 Feb; 11(2):321-6. PubMed ID: 14719062
[TBL] [Abstract][Full Text] [Related]
11. Arginase activity in prostatic tissue of patients with benign prostatic hyperplasia and prostatic carcinoma.
Harris BE; Pretlow TP; Bradley EL; Whitehurst GB; Pretlow TG
Cancer Res; 1983 Jun; 43(6):3008-12. PubMed ID: 6189588
[TBL] [Abstract][Full Text] [Related]
12. [Prostate carcinoma: higher COX-2 contents in advanced tumors].
Weiss J; Friedrich MG
Aktuelle Urol; 2004 Sep; 35(5):359-61. PubMed ID: 15383996
[No Abstract] [Full Text] [Related]
13. [LDH index in the diagnosis of prostatic diseases].
Lalanne MG; De Santis P; Mazzuca A
Minerva Urol; 1983; 35(4):243-5. PubMed ID: 6201706
[No Abstract] [Full Text] [Related]
14. Serum and urinary amylase isoenzymes in carcinoma of the prostate.
Skrha J; Stĕpán J; Pacovský V; Vachalovský V; Hradec E
Clin Chim Acta; 1982 May; 121(1):11-4. PubMed ID: 6177447
[TBL] [Abstract][Full Text] [Related]
15. Possible role of amylase enzyme in prostatic and seminal fluid.
Hanafy HM
Urol Int; 1979; 34(1):11-4. PubMed ID: 85357
[TBL] [Abstract][Full Text] [Related]
16. Isocitrate dehydrogenase activity in untreated and treated benign prostatic hypertrophy and adenocarcinomatous prostate.
Leus R; van Sande M; Van Camp K
Acta Urol Belg; 1981 Jan; 49(1):61-3. PubMed ID: 6163342
[No Abstract] [Full Text] [Related]
17. Increased serum amylase levels in prostatic diseases.
Hanafy HM; Gursel EO; Veenema RJ
Urology; 1973 Apr; 1(4):372-3. PubMed ID: 4129262
[No Abstract] [Full Text] [Related]
18. Aldolase activity in benign prostatic hypertrophy and adenocarcinomatous prostate.
Verlooy J; van Sande M; Van Camp K
Acta Urol Belg; 1980 Jan; 48(1):65-7. PubMed ID: 6159782
[No Abstract] [Full Text] [Related]
19. Effect of dutasteride on the detection of prostate cancer in men with benign prostatic hyperplasia.
Andriole GL; Roehrborn C; Schulman C; Slawin KM; Somerville M; Rittmaster RS
Urology; 2004 Sep; 64(3):537-41; discussion 542-3. PubMed ID: 15351586
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical analysis of Omi/HtrA2 expression in prostate cancer and benign prostatic hyperplasia.
Hu XY; Xu YM; Chen XC; Ping H; Chen ZH; Zeng FQ
APMIS; 2006 Dec; 114(12):893-8. PubMed ID: 17207090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
